CUSIP: 87164U201
Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
11,113,663
-
Share change
-
-748,403
-
Total reported value
-
$3,167,000
-
Price per share
-
$0.29
-
Number of holders
-
25
-
Value change
-
-$195,981
-
Number of buys
-
15
-
Number of sells
-
12
Quarterly Holders Quick Answers
What is CUSIP 87164U201?
CUSIP 87164U201 identifies SYN - THERIVA BIOLOGICS INC COM NEW - Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2022
-
Previous quarter:
Q4 2021
Recent filing periods for CUSIP 87164U201:
Institutional Holders of THERIVA BIOLOGICS INC COM NEW - Stock (SYN) as of Q1 2022
As of 31 Mar 2022,
THERIVA BIOLOGICS INC COM NEW - Stock (SYN) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,113,663 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, NORTHERN TRUST CORP, Virtu Financial LLC, JANE STREET GROUP, LLC, BLAIR WILLIAM & CO/IL, TWO SIGMA INVESTMENTS, LP, and TWO SIGMA ADVISERS, LP.
This page lists
25
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.